학술논문
Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations
Document Type
Article
Author
Source
In JTO Clinical and Research Reports February 2024 5(2)
Subject
Language
ISSN
2666-3643